Docket #: S22-449
Enhanced light gated potassium selective Channelrhodopsin
Researchers at Stanford have discovered long sought after light gated potassium selective channelrhodopsins., HcKCR1 and HcKCR2. Optogenetics is a technique where genes for light-sensitive proteins are introduced into target brain cells in order to monitor and control their activity precisely using light signals. To use them as optogenetic tools and achieve complete silencing of neurons, the researchers further solved the Cryo-EM structures and made H225F mutants, both of which show a higher K+ selectivity than the corresponding wild type.
Stage of Development
In vivo
Applications
- Silencing neurons
- Potassium selectivity in cardiac cells, kidney cells, the gastrointestinal system
- Marker for cellular functions
- Ocular diseases
Advantages
- Novel discovery of potassium selective, light gated channelrhodopsins
- Increased ability of H225F mutants to silence neurons
Publications
- Tajima, S., Kim, Y. S., et al. (2022). Structural basis for ion selectivity in potassium-selective channelrhodopsins. bioRxiv, 2022-10
Related Links
Patents
- Published Application: WO2024092248
Similar Technologies
-
System and methods for optogenetic stimulation and inhibition of pain S13-278System and methods for optogenetic stimulation and inhibition of pain
-
Structure-Guided ChRmine mutants (hs, rs and hs/rs) for red-shifted and high-speed optical activation S21-455Structure-Guided ChRmine mutants (hs, rs and hs/rs) for red-shifted and high-speed optical activation
-
Method of gene delivery to retinal astrocytes for the treatment of glaucoma and other optic neuropathies S20-457Method of gene delivery to retinal astrocytes for the treatment of glaucoma and other optic neuropathies